Toll-like receptors, and their role in inflammation as part of innate immunity. Toll-like receptor 4 or TLR4 appears to be a very good binding partner of the spike protein. TLR4s are activated by binding to the spike protein, causing inflammation of tissues that are rich in such receptors, such as the heart. An exciting compound that prevents TLR4 activation that is mentioned is naltrexone.
Described content:
TLR4 in COVID-19: [ Ссылка ]
Spike and bacteria LPS binding: [ Ссылка ]
Naltrexone: [ Ссылка ]
**** THANK YOU VERY MUCH FOR SUPPORTING OUR CHANNEL, BY MAKING A SMALL DONATION VIA THE ABOVE THANKS BUTTON. YOU ARE THE REASON WE CAN KEEP THIS CHANNEL GOING ***
"COVID-19 - Q and A for the People#11" event on ZOOM:
[ Ссылка ]
Holistic proactive wellbeing event: moneyminddna.ca
__________________________________________________________________
Dr. Raszek Credentials: [ Ссылка ]
____________________________________________________________________
Please stay in touch with us on other social media channels:
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]
LinkedIn: [ Ссылка ]
Blog: [ Ссылка ]
Newsletter Signup: [ Ссылка ]
Instagram: [ Ссылка ]
Telegram : [ Ссылка ]
